pyrazinamide has been researched along with Muscle Weakness in 2 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Muscle Weakness: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 26-year-old man, who had started treatment for pulmonary tuberculosis, developed polyarthralgia, generalised myalgia, weakness, and elevated uric acid and creatine kinase levels." | 3.81 | Drug-induced myopathy in a patient with pulmonary tuberculosis. ( Shah, R; Venkatesan, P, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, IH | 1 |
| Kim, SG | 1 |
| Kwon, JG | 1 |
| Yang, CS | 1 |
| Kang, S | 1 |
| Kim, MK | 1 |
| Ahn, DJ | 1 |
| Shah, R | 1 |
| Venkatesan, P | 1 |
2 other studies available for pyrazinamide and Muscle Weakness
| Article | Year |
|---|---|
Intestinal tuberculosis in a patient with end-stage renal disease on hemodialysis: A case report.
Topics: Anorexia; Antitubercular Agents; Drug Combinations; Ethambutol; Humans; Isoniazid; Kidney Failure, C | 2020 |
Drug-induced myopathy in a patient with pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Arthralgia; Creatine Kinase; Humans; Male; Muscle Weakness; Muscular D | 2015 |